Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “T Cell Non-Hodgkin's Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT00002557
What this trial is testing

Combination Chemotherapy in Patients With Advanced or Recurrent Mycosis Fungoides

Who this might be right for
Lymphoma
National Cancer Institute (NCI) 3
Not applicableStudy completedNCT02733458
What this trial is testing

GELAD Chemotherapy and Sandwiched Radiotherapy in the Treatment of Stage IE/IIE Natural Killer/T-cell Lymphoma

Who this might be right for
Extranodal NK-T-Cell Lymphoma, Nasal Type
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 52
Testing effectiveness (Phase 2)Ended earlyNCT00893516
What this trial is testing

CD4 in Combination With CHOP in Treating Non-cutaneous Peripheral TCell Lymphoma

Who this might be right for
T-cell Lymphoma
Emergent BioSolutions 5
Early research (Phase 1)Study completedNCT00060372
What this trial is testing

Ipilimumab After Allogeneic Stem Cell Transplant in Treating Patients With Persistent or Progressive Cancer

Who this might be right for
Adult Acute Myeloid Leukemia With 11q23 (MLL) AbnormalitiesAdult Acute Myeloid Leukemia With Inv(16)(p13;q22)Adult Acute Myeloid Leukemia With t(15;17)(q22;q12)+59 more
National Cancer Institute (NCI) 21
Large-scale testing (Phase 3)Study completedNCT00045292
What this trial is testing

Valacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell Transplantation

Who this might be right for
Cancer
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)WithdrawnNCT02118311
What this trial is testing

Treg Cells for AGVHD in Non-myeloablative UCB Transplant

Who this might be right for
Hematologic Malignancies
Masonic Cancer Center, University of Minnesota
Early research (Phase 1)Looking for participantsNCT01555892
What this trial is testing

Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE

Who this might be right for
Hodgkin's DiseaseNon-Hodgkin's LymphomaLymphoproliferative Disease+1 more
Baylor College of Medicine 136
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07682792
What this trial is testing

Golidocitinib in Patients With Mycosis Fungoides/Sézary Syndrome and T-Cell Large Granular Lymphocytic Leukemia

Who this might be right for
Mycosis Fungoides/Sezary SyndromeT-cell Large Granular Lymphocytic Leukemia
Washington University School of Medicine 24
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07276698
What this trial is testing

Clinical Study on Maintenance Therapy With Selinexor Combined With Azacitidine After Allogeneic Hematopoietic Stem Cell Transplantation for NK/T-cell Lymphoma

Who this might be right for
NK T-Cell Lymphoma
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 39
Testing effectiveness (Phase 2)Study completedNCT00109993
What this trial is testing

Campath-1H + FK506 and Methylprednisolone for GVHD

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
Case Comprehensive Cancer Center 34
Testing effectiveness (Phase 2)Study completedNCT01921387
What this trial is testing

Radiolabeled Monoclonal Antibody and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With High-Risk Lymphoid Malignancies

Who this might be right for
Recurrent B-Cell Non-Hodgkin LymphomaRecurrent Hodgkin LymphomaRecurrent Mantle Cell Lymphoma+5 more
Fred Hutchinson Cancer Center 20
Testing effectiveness (Phase 2)Ended earlyNCT00827099
What this trial is testing

Umbilical Cord Blood (UCB) Transplant, Fludarabine, Melphalan, and Anti-thymocyte Globulin (ATG) in Treating Patients With Hematologic Cancer

Who this might be right for
Myeloproliferative DisordersLeukemiaLymphoma+2 more
Northside Hospital, Inc. 5
Not applicableEnded earlyNCT00957736
What this trial is testing

Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant

Who this might be right for
Cancer
Vanderbilt-Ingram Cancer Center 252
Early research (Phase 1)Active Not RecruitingNCT00710892
What this trial is testing

CASPALLO: Allodepleted T Cells Transduced With Inducible Caspase 9 Suicide Gene

Who this might be right for
Acute Lymphoblastic LeukemiaNon-Hodgkin's LymphomaMyelodysplastic Syndrome+1 more
Baylor College of Medicine 10
Large-scale testing (Phase 3)Ended earlyNCT00127881
What this trial is testing

Study of Human Monoclonal Antibody to Treat Mycosis Fungoides and Sezary Syndrome

Who this might be right for
Mycosis FungoidesSezary Syndrome
Emergent Product Development Seattle LLC 76
Post-approval studies (Phase 4)Study completedNCT01664975
What this trial is testing

Treatment of Peripheral T-cell Lymphoma

Who this might be right for
Peripheral T-cell Lymphoma
Mingzhi Zhang 100
Testing effectiveness (Phase 2)Ended earlyNCT04541017
What this trial is testing

Testing the Addition of an Anti-cancer Drug, Hu5F9-G4 (Magrolimab), to the Usual Chemotherapy Treatment (Mogamulizumab) in T-Cell (a Type of Immune Cell) Lymphoma That Has Returned After Treatment or Does Not Respond to Treatment

Who this might be right for
Mycosis FungoidesRecurrent Mycosis FungoidesRecurrent Mycosis Fungoides and Sezary Syndrome+9 more
National Cancer Institute (NCI) 8
Early research (Phase 1)UnknownNCT05387226
What this trial is testing

Intravenous Injection of Oncolytic Virus Injection (RT-01) in Patients With Relapsed or Refractory T-cell Lymphoma

Who this might be right for
T-cell LymphomaVirusIntravenous Injection
The First Affiliated Hospital of Bengbu Medical University 6
Early research (Phase 1)UnknownNCT04118868
What this trial is testing

Pembrolizumab Administered Via the Sofusa® DoseConnect™ in Patients With Relapsed/Refractory Cutaneous T-cell Lymphoma.

Who this might be right for
Mycosis Fungoides
Sorrento Therapeutics, Inc. 10
Not applicableLooking for participantsNCT06588868
What this trial is testing

Systemic Therapies in the Treatment of Cutaneous T-cell Lymphoma

Who this might be right for
Cutaneous T Cell LymphomaCutaneous T-Cell Lymphoma/Mycosis FungoidesCutaneous T-Cell Lymphoma/Sezary Syndrome
Fondazione Italiana Linfomi - ETS 400
Next Page